2nd Jun 2006 09:00
Bespak PLC02 June 2006 Bespak plc Paul Boughton appointed Executive Director Bespak plc ("Bespak"), a leader in the design and manufacture of medical devicesfor inhaled drug delivery and anaesthesia, is pleased to announce theappointment of Paul Boughton as Executive Director. Paul joined Bespak in August 2005 as Corporate Development Director. Prior tothat he was Business Development Director, and a member of the Board of Spectrisplc. He is currently a non-executive director of Raymarine plc where he alsochairs the audit committee. He was a non-executive director of London BridgeSoftware plc from 1999 to 2004. Age 50, Paul has extensive financial and business development experience gainedover 20 years in the area of high-tech manufacturing. Having graduated with adegree in business economics, Paul qualified as a chartered accountant withDeloitte Haskins & Sells before moving into industry. Commenting on this appointment, John Robinson, Chairman, said: "I am delighted to welcome Paul to the Board of Bespak. He has already made asignificant contribution to the development of our business, and with hisextensive and relevant experience I look forward to his contribution to theBoard." Paul Boughton said: "I am delighted to be joining the Board at such an exciting time for Bespak. Theacquisition of King Systems has significantly diversified our revenues andprovides an additional platform for growth, while the recently launched Exubera(R) device is the first to deliver inhaled insulin. I look forward to continuingto work closely with Mark Throdahl and the management team to help shape Bespakfor continuing success." In accordance with Listing Rule 9.6.15, it is confirmed that there are no details to be disclosed pursuant to Listing Rule 9.6.13. For further information please contact: BespakJohn Robinson, Chairman Tel: +44 (0)20 7960 6320Mark Throdahl, Chief Executive Tel: + 44 (0)1908 552600 MaitlandBrian Hudspith or Liz Morley Tel: +44 (0)20 7379 5151 Bespak plc is a leader in specialty medical devices, developing delivery systemsfor the pharmaceutical industry and disposable airway management products forcritical care settings. The company develops and manufactures a range of devices including metered doseinhalers, dry powder devices, actuators, compliance aids, disposable facemasks,breathing circuits and laryngeal tubes. The group holds the 2005 Frost &Sullivan Award for Technology Innovation and has facilities in King's Lynn andMilton Keynes in the UK, in Indianapolis, Indiana and Kent, Ohio, in the US andin Mumbai, India. Bespak is a public company quoted on the full list of theLondon Stock Exchange (LSE: BPK). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.L